Your browser doesn't support javascript.
loading
Biopsy and re-biopsy for PD-L1 expression in NSCLC. association between PD-L1 and checkpoint inhibitor efficacy through treatment in NSCLC. A pilot study.
Zarogoulidis, Paul; Petridis, Dimitris; Huang, Haidong; Bai, Chong; Hohenforst-Schmidt, Wolfgang; Freitag, Lutz; Baka, Sofia; Drougas, Dimitris; Vagionas, Anastasios; Tsakiridis, Kosmas; Turner, J Francis; Hatzibougias, Dimitris; Boukovinas, Ioannis; Zaric, Bojan; Kovacevic, Tomi; Ioannidis, Aris; Courcoutsakis, Nikolaos; Matthaios, Dimitris; Sardeli, Chrisanthi.
Afiliação
  • Zarogoulidis P; 3rd Department of Surgery, ``ahepa`` University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece.
  • Petridis D; Pulmonary Oncology Department, ``Bioclinic`` Private Hospital, Thessaloniki, Greece.
  • Huang H; Department of Food Technology, School of Food Technology and Nutrition, Alexander Technological Educational Institute, Thessaloniki, Greece.
  • Bai C; Department of Respiratory & Critical Care Medicine, Changhai Hospital, the Second Military Medical University, Shanghai, China.
  • Hohenforst-Schmidt W; Department of Respiratory & Critical Care Medicine, Changhai Hospital, the Second Military Medical University, Shanghai, China.
  • Freitag L; Sana Clinic Group Franken, Department of Cardiology/Pulmonology/Intensive Care/Nephrology, "Hof" Clinics, University of Erlangen, Hof, Germany.
  • Baka S; Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland.
  • Drougas D; Oncology Department, ``Interbalkan`` European Medical Center, Thessaloniki, Greece.
  • Vagionas A; Nuclear Medicine Department, ``Bioiatriki`` Private PET-CT Laboratory, Thessaloniki, Greece.
  • Tsakiridis K; Oncology Department, General Hospital of Kavala, Kavala, Greece.
  • Turner JF; Thoracic Oncology Department, ``Interbalkan`` European Medical Center, Thessaloniki, Greece.
  • Hatzibougias D; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, USA.
  • Boukovinas I; Pulmonary department, Private Pathology Laboratory, "Microdiagnostics", Thessaloniki, Greece.
  • Zaric B; Oncology Department, ``Bioclinic`` Private Hospital, Thessaloniki, Greece.
  • Kovacevic T; Faculty of Medicine, University of Novi Sad, Institute for Pulmonary Diseases of Vojvodina, Novi Sad, Serbia.
  • Ioannidis A; Faculty of Medicine, University of Novi Sad, Institute for Pulmonary Diseases of Vojvodina, Novi Sad, Serbia.
  • Courcoutsakis N; Surgery Department, ``genesis`` Private HJospital, Thessaloniki, Greece.
  • Matthaios D; Radiology Department, Democritus University of Thrace, University General Hospital of Alexandroupolis, Alexandroupolis, Greece.
  • Sardeli C; Oncology Department, General Hospital of Rhodes, Thessaloniki, Greece.
Expert Rev Respir Med ; 15(11): 1483-1491, 2021 11.
Article em En | MEDLINE | ID: mdl-34591723
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antígeno B7-H1 / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Expert Rev Respir Med Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antígeno B7-H1 / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Expert Rev Respir Med Ano de publicação: 2021 Tipo de documento: Article